|
Home
> Company
> Business Services
> Advertising
> Market Research
Home > Company > Business Services > Economic Cooperation > Intellectual Property Home > Company > Business Services > Education & Training Home > Company > Chemicals > Pharmaceutical Chemicals |
|||||||||||||||||||||||||||||||||||||||||||||||
|
Drugmap covers 20,000 patent drugs from all the phases; 13,000 active clinical trials; 8,400 pharmaceutical, biotech companies, which are either drug's originators, or licensees or involved in developing or co-marketing the drug; 3,200 diseases for which the drug used; 2,000 mechanism of action; 2,500 atc tree nodes(anatomical, therapeutic, pharmacological, chemical subgroup, chemical substance); 44,000 controlled medical vocabulary; 13,000,000 searchable bibliographic information; 24,000 journals for publication planning and bibliography searching; 1,000 drug related conferences; 1,000 associations classified by therapeutic area; and 450 publishers. It provides all the information related to the drug on a daily basis. Standard tools, like search, browse, and analyze, enable you just one click away from the final results. The analysis tool provides powerful business intelligence insight for planning and decision making.
Benefits of using drugmap: 1 - easy to use 1.1 less than 3 minutes to register then access the data and tool 1.2 all the pages share the same searching and browsing interface/mechanism 1.3 minimal training needed 2 - cutting-edge technologies 2.1 cutting-edge multiple portal and internet technologies 2.2 fully personalized interface and module 2.3 powerful business intelligence tool 2.4 from simple quick search using keywords or free text to very detailed search on very focused area search, plus strong logic operation to expand or narrow your results 2.5 complete browse trees 3 - rich contents 3.1 provide most comprehensive coverage for all stages of the r&d pipeline, from early research and discovery stages through clinical trials, registration, launch, and sales. For example: - identify drugs, components - study current and future sales figures 3.2 provide most comprehensive, focused analysis and evaluation of scholarly research journals and conferences in all disciplines of science, medicine, technology and the social sciences, with advanced publication planning tool and conference planning tool. 3.3 build a complete picture on competitors activities 3.4 facilitate strategy planning by discovering new emerging areas of research 3.5 build publication planning strategy to promote drug 3.6 find out the expiration date for the drug on particular indication and country 3.7 assess potential markets, conduct world class research, be the first to the market 3.8 locate intermediaries, technology partners and suppliers Enables a variety of professionals to access and assess their related data: Clinical researchers - conduct literature searches, monitor drugs, examine conference, study competitors' drug portfolios & trials Competitive intelligence professionals - obtain patent intelligence on competitors, view current and predicted sales figures, access drug application and pipeline information, conduct literature searches, view journal and conference reports, conduct peri-launch surveillance Business development professionals - conduct literature searches, monitor competitors' activities, view journal & conference proceedings, analyze drug pipeline information, locate business partners, and technology suppliers Librarians - manage & maintain journal, conference and trials collections Publishers - calculate influence of journals Editors - assess effectiveness of editorial objectives and tracking the standing of journals Authors/writers/researchers - identify the best journals & conference to attend, submit; confirm the status of journals in which they have published, and identify journals relevant to their research, conduct literature searches Physicians - find & compare the new drug, and their adverse effects and drug interactions Biology/chemistry searchers - search chemical structures, identify new drugs and compounds, view critical research data and market drug information OEM Service: No. of R&D Staff: Estimated Annual Sales (USD): US$2.5 Million - US$5 Million Export Percentage: Quality Control: Legal Representative/CEO: Factory Size (Sq.meters): Factory Location: Corporate Status:
Other Information
|
||||||||||||||||||||||||||||||||||||||||||||||